Arrakis Therapeutics is named for the desert planet in the legendary “Dune” series of science-fiction novels. It’s an apt name because the Waltham, Mass., startup is trying to achieve a feat once thought to be biotech fantasy: Develop oral medicines — pills — that can target RNA, the messenger-like molecules that turn genetic instructions into proteins.

Scientists at Arrakis have devoted the past two years to building new computer models and rejiggering existing drug-screening tools to create a platform capable of discovering compounds that work against RNA instead of traditional disease-causing proteins.

Read the rest…

Source link